Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7241 results

Sort By:

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)

Study ID: NCT06561360
Start Date: 2024-09-09
End Date: 2027-09-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Rampheinibi

Obinutuzumab

Cladribine

Rituximab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Prospective Study to Assess a Diagnostic Aid for Cancer

Study ID: NCT07046260
Start Date: 2025-07-08
End Date: 2027-05-25
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1650

Intervention / Treatment

Blood sample collection

Sponsor

Harbinger Health

Source: clinicaltrials.gov

Share:
Add to list

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Study ID: NCT05040360
Start Date: 2022-05-05
End Date: 2027-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

141

Intervention / Treatment

Capecitabine

Temozolomide

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Thoracic Specimen Registry

Study ID: NCT04118660
Start Date: 2017-03-01
End Date: 2028-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

7000

Intervention / Treatment

Tissue Banking

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Study ID: NCT06397560
Start Date: 2025-04-30
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

28

Intervention / Treatment

Prdro

Sponsor

Baptist Health South Florida

Source: clinicaltrials.gov

Share:
Add to list

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Study ID: NCT03850366
Start Date: 2016-03-08
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

Bortezomib

Sponsor

Henry Ford Health System

Source: clinicaltrials.gov

Share:
Add to list

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Study ID: NCT06159166
Start Date: 2024-02-12
End Date: 2028-11-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Mirdamet

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Study ID: NCT07021066
Start Date: 2025-07-30
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

BL-M05D1

Sponsor

SystImmune Inc.

Source: clinicaltrials.gov

Share:
Add to list

PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery

Study ID: NCT05520866
Start Date: 2023-03-14
End Date: 2026-04-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

132

Intervention / Treatment

PrehabPal

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

Study ID: NCT06834126
Start Date: 2025-04-07
End Date: 2028-09-19
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Consolidation Therapy

Functional Magnetic Resonance Imaging

Gastrointestinal Endoscopy

Magnetic Resonance Imaging

Papaverine

Radiation Therapy

Total Mesorectal Excision

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list